SKI Market

A+| A| A-|

Indian Indices

Sensex

77,185.56 -430.84
( -0.56%)

Global Indices

Nasdaq

52,524.20 -133.81
(-0.25%)

Dow Jones

7,536.77 -59.62
(-0.78%)

Hang Seng

67,217.35 -1,340.38
(-1.96%)

Nikkei 225

10,494.06 -3.23
(-0.03%)

Forex

USD-INR

95.45 -0.01
(-0.01%)

EUR-INR

109.10 0.17
(0.15%)

GBP-INR

127.94 0.35
(0.28%)

JPY-INR

0.59 0.00
(0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

17.5524281

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

34.74

53.85

EPS(TTM)

Face Value()

Div & Yield %

1.08

Back

Board of Mangalam Worldwide recommends final dividend

Apr 30,2026

Mangalam Worldwide announced that the Board of Directors of the Company at its meeting held on 29 April 2026, inter alia, have recommended the final dividend of Rs 0.3 per equity Share (i.e. 3%) , subject to the approval of the shareholders.

77,185.56 -430.84 ( -0.56%)

52,524.20 -133.81 (-0.25%)

7,536.77 -59.62 (-0.78%)

67,217.35 -1,340.38 (-1.96%)

10,494.06 -3.23 (-0.03%)

95.45 -0.01 (-0.01%)

109.10 0.17 (0.15%)

127.94 0.35 (0.28%)

0.59 0.00 (0.03%)